HQY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HQY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HealthEquity's annualized ROCE % for the quarter that ended in Jan. 2024 was 5.74%.
The historical data trend for HealthEquity's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity Annual Data | |||||||||||||||||||||
Trend | Jan15 | Jan16 | Jan17 | Jan18 | Jan19 | Jan20 | Jan21 | Jan22 | Jan23 | Jan24 | |||||||||||
ROCE % | Get a 7-Day Free Trial | 4.69 | 1.59 | -1.11 | 0.35 | 4.35 |
HealthEquity Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
ROCE % | Get a 7-Day Free Trial | 1.94 | 3.39 | 3.72 | 4.65 | 5.74 |
HealthEquity's annualized ROCE % for the fiscal year that ended in Jan. 2024 is calculated as:
ROCE % | = | EBIT | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(A: Jan. 2024 ) | (A: Jan. 2023 ) | (A: Jan. 2024 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(A: Jan. 2024 ) | (A: Jan. 2023 ) | (A: Jan. 2024 ) | |||||
= | 130.495 | / | ( ( (3088.9 - 131.061) | + | (3163.79 - 117.091) ) | / 2 ) | |
= | 130.495 | / | ( (2957.839 | + | 3046.699) | / 2 ) | |
= | 130.495 | / | 3002.269 | ||||
= | 4.35 % |
HealthEquity's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:
ROCE % | = | EBIT (1) | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(Q: Jan. 2024 ) | (Q: Oct. 2023 ) | (Q: Jan. 2024 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(Q: Jan. 2024 ) | (Q: Oct. 2023 ) | (Q: Jan. 2024 ) | |||||
= | 173.432 | / | ( ( (3093.502 - 96.236) | + | (3163.79 - 117.091) ) | / 2 ) | |
= | 173.432 | / | ( ( 2997.266 | + | 3046.699 ) | / 2 ) | |
= | 173.432 | / | 3021.9825 | ||||
= | 5.74 % |
(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (NAS:HQY) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Thank you for viewing the detailed overview of HealthEquity's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Delano Ladd | officer: Executive VP, GC & Corp. Secy. | 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020 |
Ian Sacks | director | TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022 |
Elimelech Rosner | officer: EVP, Chief Technology Officer | 5196 BELMORE COURT, SUWANEE GA 30024 |
Stephen Neeleman | director, officer: Founder and Vice Chairman | 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020 |
Tyson D. Murdock | officer: EVP & CFO | 2275 S. 2200 E., SALT LAKE CITY UT 84109 |
Jon Kessler | director, officer: President and CEO | 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020 |
Frank Corvino | director | GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830 |
Larry L Trittschuh | officer: EVP Chief Security Officer | 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419 |
James M Lucania | officer: EVP & CFO | 101 WOLF DRIVE, THOROFARE NJ 08086 |
Gayle Furgurson Wellborn | director | 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117 |
Debra Charlotte Mccowan | director | 1436 CABRILLO AVENUE, BURLINGAME CA 94010 |
Paul Black | director | 400 WOOD ROAD, BRAINTREE MA 02184 |
Edward Bloomberg | officer: Chief Operating Officer | 13207 WINDSOR STREET, LEAWOOD KS 66209 |
Rajesh Natarajan | director | 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024 |
Evelyn S Dilsaver | director | C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596 |
From GuruFocus
By Marketwired • 07-18-2023
By GuruFocus Research • 12-05-2023
By Value_Insider Value_Insider • 12-13-2022
By GuruFocus Research • 09-19-2023
By Marketwired • 09-19-2023
By Ds*** Ds*** • 09-01-2022
By GuruFocus Research • 09-06-2023
By Stock market mentor Stock market mentor • 02-07-2023
By Marketwired • 09-05-2023
By Marketwired • 09-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.